You are here

Article Text

Article menu
Download PDFPDF
Original article
Randomised controlled trial of aminophylline for severe acute asthma
  1. Michael Yung,
  2. Mike South
  1. Intensive Care Unit, Royal Children’s Hospital, Melbourne, Victoria 3052, Australia
  1. Dr South. email:south{at}cryptic.rch.unimelb.edu.au

Abstract

OBJECTIVES To determine whether children with severe acute asthma treated with large doses of inhaled salbutamol, inhaled ipratropium, and intravenous steroids are conferred any further benefits by the addition of aminophylline given intravenously.

STUDY DESIGN Randomised, double blind, placebo controlled trial of 163 children admitted to hospital with asthma who were unresponsive to nebulised salbutamol.

RESULTS The placebo and treatment groups of children were similar at baseline. The 48 children in the aminophylline group had a greater improvement in spirometry at six hours and a higher oxygen saturation in the first 30 hours. Five subjects in the placebo group were intubated and ventilated after enrolment compared with none in the aminophylline group.

CONCLUSIONS Aminophylline continues to have a place in the management of severe acute asthma in children unresponsive to initial treatment.

  • asthma
  • aminophylline
  • randomised controlled trial

https://doi.org/10.1136/adc.79.5.405

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes